Back to top
more

UnitedHealth Group (UNH)

(Delayed Data from NYSE)

$250.89 USD

250.89
10,156,220

+6.22 (2.54%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $250.96 +0.07 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 7% (228 out of 244)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Zacks Equity Research

UnitedHealth Group (UNH) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed the most recent trading day at $353.88, moving -0.6% from the previous trading session.

Zacks Equity Research

UnitedHealth (UNH) Invests in Technology to Lead the Industry

by Zacks Equity Research

The breakout of COVID-19 fuels the use of technology in the healthcare space and UnitedHealth (UNH) is promptly acting on this to ramp up its technological innovations.

Zacks Equity Research

The Zacks Analyst Blog Highlights: UnitedHealth Group, Pfizer, International Business Machines, Humana and Exelon

by Zacks Equity Research

The Zacks Analyst Blog Highlights: UnitedHealth Group, Pfizer, International Business Machines, Humana and Exelon

Sheraz Mian headshot

Top Analyst Reports for UnitedHealth, Pfizer & IBM

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), Pfizer (PFE), and International Business Machines (IBM).

Zacks Equity Research

UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed at $351.98 in the latest trading session, marking a +0.52% move from the prior day.

Zacks Equity Research

Humana (HUM) Unit Expands to Meet Senior-Focused Health Needs

by Zacks Equity Research

Humana's (HUM) subsidiary Conviva acquires a primary care physician network in South Florida for boosting healthcare services offered to seniors across the region.

Zacks Equity Research

UnitedHealth Group (UNH) Stock Moves -0.53%: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed the most recent trading day at $332.87, moving -0.53% from the previous trading session.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth Group, Comcast, QUALCOMM and Micron Technology

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Johnson & Johnson, UnitedHealth Group, Comcast, QUALCOMM and Micron Technology

Mark Vickery headshot

Top Stock Reports for Johnson & Johnson, UnitedHealth & Comcast

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), UnitedHealth Group (UNH), and Comcast (CMCSA).

Zacks Equity Research

Cigna (CI) Set to Expand in Telehealth Via MDLIVE Buyout

by Zacks Equity Research

Cigna (CI) is set to buy MDLIVE, a provider of telehealth services, to gain share in the growing market.

Zacks Equity Research

Magellan's (MGLN) Q4 Earnings Miss Estimates, Decline Y/Y

by Zacks Equity Research

Magellan Health's (MGLN) results reflect a decline in earnings and revenues due to lower contribution from Healthcare and Pharmacy Management units.

Zacks Equity Research

Humana (HUM), Mercy Tie Up to Extend Telehealth Services

by Zacks Equity Research

Humana (HUM) partners with Mercy to expand virtual care services for members.

Zacks Equity Research

UnitedHealth Group (UNH) Stock Moves -1.01%: What You Should Know

by Zacks Equity Research

UnitedHealth Group (UNH) closed the most recent trading day at $328.87, moving -1.01% from the previous trading session.

Zacks Equity Research

Why Is UnitedHealth (UNH) Down 7.5% Since Last Earnings Report?

by Zacks Equity Research

UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Humana (HUM) to Offer Integrated Care to Specific MA Members

by Zacks Equity Research

Humana (HUM) unveils Humana Care Support driven by data and analytics in a bid to offer personalized care to a selected group of Medicare Advantage members.

Zacks Equity Research

Molina Healthcare (MOH) Posts Q4 Loss, Misses on Revenues

by Zacks Equity Research

Molina Healthcare's (MOH) fourth-quarter results reflect escalating expenses.

Zacks Equity Research

Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Tenet Healthcare's (THC) Q4 earnings improve on the back of better revenues.

Zacks Equity Research

Centene (CNC) Q4 Earnings Surpass Estimates, Tumble Y/Y

by Zacks Equity Research

Centene (CNC) Q4 results gain from improved revenues as well as better membership.

Zacks Equity Research

Cigna (CI) Q4 Earnings Miss, Decline Y/Y on Elevated Claims

by Zacks Equity Research

Cigna's (CI) Q4 results reflect higher revenues, partly offset by an increase in COVID-related claims that eroded its bottom line.

Zacks Equity Research

Ensign Group's (ENSG) Q4 Earnings Top Estimates, Improve Y/Y

by Zacks Equity Research

Ensign Group's (ENSG) fourth-quarter results reflect a year-over-year rise in revenues.

Zacks Equity Research

Humana's (HUM) Q4 Loss Narrower Than Expected, Tumble Y/Y

by Zacks Equity Research

Humana's (HUM) fourth-quarter results reflect elevated costs related to COVID-19 along with high marketing expenses.

Zacks Equity Research

Anthem's (ANTM) Buyout to Offer Better Healthcare in Puerto Rico

by Zacks Equity Research

Anthem (ANTM) acquires subsidiaries of InnovaCare Health in a bid to facilitate improved health outcomes across Puerto Rico.

Zacks Equity Research

HCA Healthcare's (HCA) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

HCA Healthcare's (HCA) fourth-quarter earnings gain on the back of better revenues.

Kevin Cook headshot

Bull of the Day: Vericel (VCEL)

by Kevin Cook

Restoring cartilage in sports medicine and rebuilding skin after severe burns gave this small-cap big upside

Zacks Equity Research

Encompass Health (EHC) Q4 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Encompass Health's (EHC) fourth-quarter results gain from improved revenues and lower costs, partly offset by lower volumes in both its segments.